The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

[1]  D. Maraganore,et al.  Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium , 2013, Movement disorders : official journal of the Movement Disorder Society.

[2]  E. Katunina,et al.  [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[3]  C. Tanner,et al.  Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. , 2012, Parkinsonism & related disorders.

[4]  I. Guella,et al.  SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population , 2012, Parkinsonism & related disorders.

[5]  Chuong B. Do,et al.  Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.

[6]  Sebastian M. Armasu,et al.  Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility? , 2011, Parkinsonism & related disorders.

[7]  J. Ioannidis,et al.  Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study , 2011, The Lancet Neurology.

[8]  M. Farrer,et al.  SNCA, MAPT, and GSK3B in Parkinson disease: a gene–gene interaction study , 2011, European journal of neurology.

[9]  J. Hardy,et al.  Milestones in PD genetics , 2011, Movement disorders : official journal of the Movement Disorder Society.

[10]  J. Zeng,et al.  LRRK2 R1398H polymorphism is associated with decreased risk of Parkinson's disease in a Han Chinese population. , 2011, Parkinsonism & related disorders.

[11]  A. Destée,et al.  Independent and joint effects of the MAPT and SNCA genes in Parkinson disease , 2011, Annals of neurology.

[12]  Mohamad Saad,et al.  Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies , 2011, The Lancet.

[13]  J. Jankovic,et al.  Multiple LRRK2 variants modulate risk of Parkinson disease: a chinese multicenter study , 2010, Human mutation.

[14]  M. Farrer,et al.  Association of the MAPT locus with Parkinson’s disease , 2010, European journal of neurology.

[15]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[16]  R. Postuma,et al.  Predicting Parkinson's disease - why, when, and how? , 2009, Parkinsonism & related disorders.

[17]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[18]  K. Doheny,et al.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease , 2009, Human Genetics.

[19]  H. Shill,et al.  Haplotypes and gene expression implicate the MAPT region for Parkinson disease , 2008, Neurology.

[20]  M. Farrer,et al.  Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease , 2008, Annals of neurology.

[21]  Colin C. McCulloch,et al.  Exploring gene-environment interactions in Parkinson’s disease , 2008, Human Genetics.

[22]  M. Farrer,et al.  α-Synuclein and Parkinson disease susceptibility , 2007, Neurology.

[23]  M. Farrer,et al.  Familial genes in sporadic disease: Common variants of α-synuclein gene associate with Parkinson's disease , 2007, Mechanisms of Ageing and Development.

[24]  M. Farrer,et al.  Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. , 2007, Parkinsonism & related disorders.

[25]  M. Farrer,et al.  alpha-Synuclein and Parkinson disease susceptibility. , 2007, Neurology.

[26]  M. Ban,et al.  Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. , 2007, Annals of neurology.

[27]  Aldo Quattrone,et al.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. , 2006, JAMA.

[28]  B. Oostra,et al.  A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan , 2006, Neurogenetics.

[29]  H. Inoko,et al.  Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. , 2006, Human molecular genetics.

[30]  M. Farrer,et al.  Interaction of α‐synuclein and tau genotypes in Parkinson's disease , 2005 .

[31]  M. Farrer,et al.  Interaction of alpha-synuclein and tau genotypes in Parkinson's disease. , 2005, Annals of neurology.

[32]  A. Singleton,et al.  The tau H2 haplotype is almost exclusively Caucasian in origin , 2004, Neuroscience Letters.

[33]  M. Farrer,et al.  Linkage disequilibrium and association of MAPT H1 in Parkinson disease. , 2004, American journal of human genetics.

[34]  A J Lees,et al.  Tau gene and Parkinson’s disease: a case–control study and meta-analysis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[35]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[36]  R. Krüger,et al.  Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype , 1999, Annals of neurology.

[37]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[38]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[39]  H. Payami,et al.  Genetic Epidemiology of Parkinson's Disease , 1998, Journal of geriatric psychiatry and neurology.

[40]  S. Goodman,et al.  The Use of Predicted Confidence Intervals When Planning Experiments and the Misuse of Power When Interpreting Results , 1994, Annals of Internal Medicine.

[41]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[42]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[43]  C R Weinberg,et al.  Applicability of the simple independent action model to epidemiologic studies involving two factors and a dichotomous outcome. , 1986, American journal of epidemiology.